Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Oncology Institute (TOI) Shares Repurchased (2023)

Oncology Institute (TOI) has disclosed Shares Repurchased for 2 consecutive years, with $125000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Shares Repurchased changed N/A year-over-year to $125000.0, compared with a TTM value of $125000.0 through Dec 2024, changed 0.0%, and an annual FY2023 reading of $1.0 million, down 88.68% over the prior year.
  • Shares Repurchased was $125000.0 for Q3 2023 at Oncology Institute, down from $9.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $9.0 million in Q2 2022 and bottomed at $125000.0 in Q3 2023.